Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Stomach Neoplasms × Trifluridine × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 10 Colonic Neoplasms 2 Stomach Neoplasms 1 Gastric Cancer Adenocarcinoma Metastatic 1 Clinical Stage III Gastric Cancer AJCC v8 1 Advanced/Metastatic Solid Tumors 1

Interventions

Oxaliplatin 38 Fluorouracil 27 pembrolizumab 21 Capecitabine 21 Paclitaxel 18 Leucovorin 17 S 1 (combination) 14 Docetaxel 13 tislelizumab 11 Nivolumab 11 Cisplatin 10 sintilimab 9 Trastuzumab 9 Irinotecan 9 trastuzumab deruxtecan 8 Drug Therapy 8 Biopsy 8 Surgical Procedures, Operative 7 Specimen Handling 7 Bevacizumab 7 fludarabine 6 disitamab vedotin 6 apatinib 6 XELOX 6 Radiotherapy 6 Magnetic Resonance Spectroscopy 6 Hyperthermic Intraperitoneal Chemotherapy 6 Cyclophosphamide 6 spartalizumab 5 lenvatinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07212933 2025-10-08

RAK in GC

Chinese PLA General Hospital

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡